Advertisement

Contrast Agents in Childhood: Application and Safety Considerations

  • Michael Riccabona
  • Hans-Joachim Mentzel
Chapter
Part of the Medical Radiology book series (MEDRAD)

Abstract

Contrast agents are essential for a number of radiological studies in children; most of them are handled and excreted by the kidney. This chapter tries to summarize the relevant contrast agents handled by the kidney that are used in childhood imaging, to give some considerations toward age and weight-adapted dose, and to discuss safety issues including precautions helpful to avoid complications or their sequelae. Contrast agents and applications outside the genitourinary tract as well as those not primarily handled by the kidney are not addressed – a comprehensive summary of all potential applications and risks can be found in the recently updated book entitled Contrast Media: Safety Issues and ESUR Guidelines (Thomsen et al. 2014).

References

  1. American College of Radiology – ACR 2012/manual on contrast media v8 – contrast media in children. http://www.acr.org/Quality-Safety/Resources/Contrast-Manual
  2. Ascenti G, Zimbaro G, Mazziotti S et al (2004) Harmonic US imaging of vesicoureteric reflux in children: usefulness of a second generation US contrast agent. Pediatr Radiol 34:481–487PubMedGoogle Scholar
  3. Berrocal T, Gaya F, Arjonilla A et al (2001) Vesicoureteral reflux: diagnosis and grading with echo-enhanced cystosonography versus voiding cystourethrography. Radiology 221:359–365PubMedGoogle Scholar
  4. Berrocal T, Gaya F, Arjonilla A (2005) Vesicoureteral reflux: can the urethra be adequately assessed by using contrast-enhanced voiding US of the bladder? Radiology 234:235–241, 650PubMedGoogle Scholar
  5. Bosio M, Manzoni GA (2002) Detection of posterior urethral valves with voiding cysto-urethrosonography with echo contrast. J Urol 168:1711–1715PubMedGoogle Scholar
  6. Brasch RC (2008) Contrast media toxicity in children. Pediatr Radiol 38(S2):S281–S284PubMedGoogle Scholar
  7. Calliada F, Campani R, Bottinelli O, Bozzini A, Sommaruga MG (1998) Ultrasound contrast agents: basic principles. Eur J Radiol 27(S2):S157–S160PubMedGoogle Scholar
  8. Darge K (2008) Voiding urosonography with ultrasound contrast agents for the diagnosis of vesicoureteric reflux in children. I. Procedure. Pediatr Radiol 38:40–53PubMedGoogle Scholar
  9. Darge K (2010) Voiding urosonography with US contrast agent for the diagnosis of vesicoureteric reflux in children: an update. Pediatr Radiol 40:956–962PubMedGoogle Scholar
  10. Darge K, Zieger B, Rohrschneider W et al (2001) Reduction in voiding cystourethrographies after the introduction of contrast enhanced sonographic reflux diagnosis. Pediatr Radiol 31:790–795PubMedGoogle Scholar
  11. Darge K, Papadopoulou F, Ntoulia A, Bulas DI, Coley BD, Fordham LA, Paltiel HJ, McCarville B, Volberg FM, Cosgrove DO, Goldberg BB, Wilson SR, Feinstein SB (2013) Safety of contrast-enhanced ultrasound in children for non-cardiac applications: a review by the Society for Pediatric Radiology (SPR) and the International Contrast Ultrasound Society (ICUS). Pediatr Radiol 43:1063–1073PubMedGoogle Scholar
  12. Davenport MS, Khalatbari S, Dillman JR, Cohan RH, Caoili EM, Ellis JH (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology 267:94–105. doi: 10.2214/AJR.14.13761 PubMedPubMedCentralGoogle Scholar
  13. Dawson P, Becker A, Holton JM (1983) The effect of contrast media on the growth of bacteria. Br J Radiol 56:809–815PubMedGoogle Scholar
  14. Dharnidharka VR, Wesson SK, Fennell RS (2007) Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 22:1395PubMedGoogle Scholar
  15. Duran C, Valera A, Alguersuari A et al (2009) Voiding urosonography: the study of the urethra is no longer a limitation of the technique. Pediatr Radiol 39:124–131PubMedGoogle Scholar
  16. EMA’s final opinion confirms restrictions on use of linear gadolinium agents in body scans (2017). EMA/457616/2017, last visited April 2018. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/gadolinium_contrast_agents_31/Opinion_provided_by_Committee_for_Medicinal_Products_for_Human_Use/WC500231824.pdf
  17. Esposito F, Di Serafino M, Sgambati P, Mercogliano F, Tarantino L, Vallone G, Oresta P (2012) Ultrasound contrast media in paediatric patients: is it an off-label use? Regulatory requirements and radiologist’s liability. Radiol Med 117:148–159PubMedGoogle Scholar
  18. Foss C, Smith JK, Ortiz L, Hanevold C, Davis L (2009) Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy. Pediatr Dermatol 26:579–582PubMedGoogle Scholar
  19. Frush DP (2008) Pediatric abdominal CT angiography. Pediatr Radiol 38(S2):S259–S266PubMedGoogle Scholar
  20. Garfinkle MA, Stewart S, Basi R (2015) Incidence of ct contrast agent–induced nephropathy: toward a more accurate estimation. AJR Am J Roentgenol 204:1146–1151. doi: 10.2214/AJR.14.13761 PubMedGoogle Scholar
  21. Hahn G, Sorge I, Gruhn B et al (2009) Pharmacokinetics and safety of gadobutrol-enhanced magnetic resonance imaging in pediatric patients. Invest Radiol 44:776–783PubMedGoogle Scholar
  22. Heran MK, Marshalleck F, Temple M et al. Society of Interventional Radiology Standards of Practice Committee; Society of Pediatric Radiology Interventional Radiology Committee (2010) Joint quality improvement guidelines for pediatric arterial access and arteriography: from the Societies of Interventional Radiology and Pediatric Radiology. Pediatr Radiol 40:237–250PubMedGoogle Scholar
  23. Hiorns MP (2011) Gastrointestinal tract imaging in children: current techniques. Pediatr Radiol 41:42–54PubMedGoogle Scholar
  24. Jain SM, Wesson S, Hassanein A et al (2004) Nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 19:467–470PubMedGoogle Scholar
  25. Kalmar P, Riccabona M (2013) Intramedulläre Gadoliniumresiduen in Nieren pädiatrischer Onkologie-Patienten – ein Wort zur Vorsicht. 50. GPR Jahrestagung, Jena, September 2013. Fortschr Röntgenstr (RöFo) 185:893 (abstract)Google Scholar
  26. Karcaaltincaba M, Oguz B, Haliloglu M (2009) Current status of contrast-induced nephropathy and nephrogenic systemic fibrosis in children. Pediatr Radiol 39(S3):S382–S384Google Scholar
  27. Kurian J, Epelman M, Darge K et al (2013) The role of CT angiography in the evaluation of pediatric renovascular hypertension. Pediatr Radiol 43:490–501PubMedPubMedCentralGoogle Scholar
  28. Mannelli L, Maki JH, Osman SF et al (2012) Non-contrast functional MRI of the kidneys. Curr Urol Rep 13:99–107PubMedGoogle Scholar
  29. McCarville MB (2011) Contrast-enhanced sonography in pediatrics. Pediatr Radiol 41(S1):S238–S242PubMedGoogle Scholar
  30. McDonald RJ, McDonald JS., Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275:772–7782. doi:http://dx.doi.org/10.1148/radiol.15150025 CrossRefPubMedGoogle Scholar
  31. Mendichovszky IA, Marks SD, Simcock CM, Olsen OE (2008) Gadolinium and nephrogenic systemic fibrosis: time to tighten practice. Pediatr Radiol 38:489–496PubMedGoogle Scholar
  32. Mentzel HJ, Vogt S, Patzer L, Schubert R, John U, Misselwitz J, Kaiser WA (1999) Contrast-enhanced sonography of vesicoureteral reflux in children: preliminary results. Am J Roentgenol 173:737–740Google Scholar
  33. Mikkonen R, Kontkanen T, Kivisaari L (1995) Late and acute adverse reactions to iohexol in a pediatric population. Acta Radiol 35:350–352PubMedGoogle Scholar
  34. Morcos SK (2007) Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition? Br J Radiol 80:73–76, Erratum in: Br J Radiol 2007;80:586PubMedGoogle Scholar
  35. Newhouse JH, Kho D, Rao QA, Starren J (2008) Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 191:376–382. doi: 10.2214/AJR.14.13761 PubMedGoogle Scholar
  36. Papadopoulou F, Ntoulia A, Siomou E, Darge K (2014) Contrast-enhanced voiding urosonography with intravesical administration of a second-generation ultrasound contrast agent for diagnosis of vesicoureteral reflux: prospective evaluation of contrast safety in 1,010 children. Pediatr Radiol 44:719–728PubMedGoogle Scholar
  37. Pärtan G (2014) Radiography and fluoroscopy. In: Riccabona M (ed) Pediatric imaging essentials. Thieme, Stuttgart/New-York, pp 10–19. ISBN 987-3-13-166191-3Google Scholar
  38. Penfield JG, Reilly RF (2008) Nephrogenic systemic fibrosis risk: is there a difference between gadolinium-based contrast agents? Semin Dial 21:129–134PubMedGoogle Scholar
  39. Piscaglia F, Bolondi L (2006) The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32:1369–1375PubMedGoogle Scholar
  40. Piskunowicz M, Kosiak W, Irga N (2011) Primum non nocere? Why can’t we use second generation ultrasound contrast agents for the examination of children? Ultraschall Med 32:83–86PubMedGoogle Scholar
  41. Piskunowicz M, Kosiak W, Batko T (2012) Intravenous application of second-generation ultrasound contrast agents in children: a review of the literature. Ultraschall Med 33:135–140PubMedGoogle Scholar
  42. Riccabona M (2002) Cystography in infants and children: a critical appraisal of the many forms with special regard to voiding cystourethrography. Eur Radiol 12:2910–2918PubMedGoogle Scholar
  43. Riccabona M (2012) Application of a second-generation US contrast agent in infants and children – a European questionnaire-based survey. Pediatr Radiol 42:1471–1480PubMedGoogle Scholar
  44. Riccabona M (2014) Contrast media use in pediatrics: safety issues. In: Thomsen HS, Webb JAW (eds) Contrast media. Safety issues and ESUR guidelines, 3rd edn. Springer, Heidelberg/New-York/Dordrecht/London, pp 245–253. ISBN 978-3-642-36723-6Google Scholar
  45. Riccabona M, Avni FE, Blickman JG et al (2008) Imaging recommendations in paediatric uroradiology: minutes of the ESPR workgroup session on urinary tract infection, fetal hydronephrosis, urinary tract ultrasonography and voiding cystourethrography. Barcelona, Spain, June 2007. Pediatr Radiol 38:138–145PubMedGoogle Scholar
  46. Riccabona M, Avni FE, Blickman JG, Dacher JN, Darge K, Lobo ML, Willi U, Members of the ESUR Paediatric Paediatric Recommendation Work Group and ESPR Paediatric Uroradiology Work Group (2009) Imaging recommendations in paediatric uroradiology, part II: urolithiasis and haematuria in children, paediatric obstructive uropathy, and postnatal work-up of foetally diagnosed high grade hydronephrosis. Minutes of a mini-symposium at the ESPR annual meeting, Edinburg, June. Pediatr Radiol 39:891–898PubMedPubMedCentralGoogle Scholar
  47. Riccabona M, Avni F, Damasio B et al (2012) ESPR Uroradiology Task Force and ESUR Paediatric Working Group: imaging recommendations in paediatric uroradiology, part V: childhood cystic kidney disease, childhood renal transplantation and contrast-enhanced ultrasound in children. Pediatr Radiol 42:1275–1283PubMedGoogle Scholar
  48. Schreiber-Dietrich D, Dietrich CF (2012) Contrast enhanced ultrasound (CEUS) and off-label use (in children). Ultraschall Med 33:295–296PubMedGoogle Scholar
  49. Sorantin E, Weissensteiner S, Hasenburger G, Riccabona M. CT in children - dose protection and generalconsiderations when planning a CT in a child. Eur Radiol 2013; 82 (7): 1043-1049.PubMedGoogle Scholar
  50. Sorantin E (2013) Special aspects of computed tomography in children. In: Riccabona M (ed) Pediatric imaging essentials. Thieme, Stuttgart/New-York, pp 22–28. ISBN 987-3-13-166191-3Google Scholar
  51. Sorantin E, Zsivcsec B, Zebedin D, Fotter R (2002) Optimierung von i.v. Kontrastmittel-applikatonen für pädiatrische Spiral-CT Untersuchungen (Optimisation of i.v. contrast application for pediatric spiral-CT). Radiologe 45:683–684Google Scholar
  52. Sorantin E, Weissensteiner S, Hasenburger G, Riccabona M (2013) CT in children – dose protection and general considerations when planning a CT in a child. Eur J Radiol 82:1043–1049PubMedGoogle Scholar
  53. Speck U (1999) Kontrastmittel: Übersicht, Anwendung und pharmazeutische Aspekte [Contrast Media. overview, use and pharmaceutical aspects]. Springer, Berlin, pp 16–17. ISBN 978-3-540-65712-5Google Scholar
  54. Stenzel M (2013) Intravenous contrast-enhanced sonography in children and adolescents – a single center experience. J Ultrason 13:133–144PubMedPubMedCentralGoogle Scholar
  55. Stenzel M, Mentzel HJ (2014) Ultrasound elastography and contrast-enhanced ultrasound in infants, children and adolescents. Eur J Radiol 83:1560–1569PubMedGoogle Scholar
  56. ter Haar G (2009) Safety and bio-effects of ultrasound contrast agents. Med Biol Eng Comput 47:893–900PubMedGoogle Scholar
  57. Thaker VV, Leung AM, Braverman LE, Brown RS, Levine B (2014) Iodine-induced hypothyroidism in full-term infants with congenital heart disease: more common than currently appreciated? J Clin Endocrinol Metab 99:3521–3526. doi: 10.1210/jc.2014-1956 PubMedPubMedCentralGoogle Scholar
  58. Thomsen HS, Webb JAW (eds) (2014) Contrast media. Safety issues and ESUR guidelines, 3rd edn. Springer, Heidelberg/New-York/Dordrecht/London. ISBN 978-3-642-36723-6Google Scholar
  59. Torzilli G (2005) Adverse effects associated with SonoVue use. Expert Opin Drug Saf 4:399–401PubMedGoogle Scholar
  60. Valentini AL, De Gaetano AM, Destito C et al (2002) The accuracy of voiding urosonography in detecting vesico-ureteral reflux: a summary of existing data. Eur J Pediatr 161:380–384PubMedGoogle Scholar
  61. Valentino M, Serra C, Pavlica P et al (2008) Blunt abdominal trauma: diagnostic performance of contrast-enhanced US in children – initial experience. Radiology 246:903–909PubMedGoogle Scholar
  62. Webb JAW (2014) Pregnancy and lactation: intravascular use of contrast media. In: Thomsen HS, Webb JAW (eds) Contrast media: safety issues and ESUR guidelines, 3rd edn. Springer, Heidelberg/New-York/Dordrecht/London, pp 113–121. ISBN 978-3-642-36723-6Google Scholar
  63. Zerin JM (1992) Contrast studies of the gastrointestinal tract in the neonate. Semin Pediatr Surg 1:284–295PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Radiology, Division of Pediatric RadiologyUniversity Hospital GrazGrazAustria
  2. 2.Section of Paediatric Radiology, Institute of Diagnostic and Interventional RadiologyUniversity Hospital JenaJenaGermany

Personalised recommendations